AstraZeneca PLC is 1.3x more valuable than GSK plc by market capitalization ($286.27 B vs $221.53 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AZN | GSK |
|---|---|---|
| Market cap | $286.27 B | $221.53 B |
| US-listed rank | #45 | #62 |
| SEC filings | 1,004 | 988 |
AstraZeneca PLC is 1.3x more valuable than GSK plc by market capitalization ($286.27 B vs $221.53 B).
Full pages: AstraZeneca PLC and GSK plc, or browse the full rankings.